Top News Stories
Drug Label Decision Should Not Affect Rates, Says Expert
By Daniel HaysThe U.S. Supreme Court ruling that drug manufacturers' federally approved labeling does not protect them from state lawsuits should not raise insurance rates for pharmaceutical companies, according
